Bifidobacterium breve
Scientific names: Bifidobacterium breve
Family: Bifidobacteriaceae
Alternate names: B. Breve, Probiotic, Probiotique
Background
Bifidobacterium breve (B. breve) is a type of probiotic ("good" bacteria) that lives in the intestines.
It produces lactic and acetic acid in the gut.
"Good" bacteria such as B. breve can help break down food, absorb nutrients, and fight off "bad" organisms that might cause diseases. B. breve is commonly found in the gut of breastfed infants and in the vagina.
People use B. breve for age-related decline in memory and thinking, blood infections, and many other purposes, but there is no good scientific evidence to support these uses. There is also no good evidence to support using B. breve for COVID-19.
Don't confuse B. breve with other probiotics, or with fermented food products such as fermented milk, kefir, or yogurt. These are not the same.
"Good" bacteria such as B. breve can help break down food, absorb nutrients, and fight off "bad" organisms that might cause diseases. B. breve is commonly found in the gut of breastfed infants and in the vagina.
People use B. breve for age-related decline in memory and thinking, blood infections, and many other purposes, but there is no good scientific evidence to support these uses. There is also no good evidence to support using B. breve for COVID-19.
Don't confuse B. breve with other probiotics, or with fermented food products such as fermented milk, kefir, or yogurt. These are not the same.
Safety Safety definitions
When taken by mouth: B. breve is likely safe. It's been used safely alone and together with other probiotics for up to one year. Some people might experience gas and bloating from probiotics, but B. breve seems to be well-tolerated.
Children: B. breve is likely safe for most children when taken by mouth for up to one year. However, there isn't enough reliable information to know if B. breve is safe for very small premature infants. There have been cases of blood infection with B. breve in critically ill babies.
Weakened immune system: B breve has caused blood infections in a small number of people with weakened immune systems. If you have a weakened immune system, talk with your healthcare provider before taking B. breve.
Blockage in the intestines: B. breve has caused blood infections in a small number of infants who have had stomach surgery. Because the intestines became blocked, the bacteria might have crossed into the blood stream. Use cautiously or avoid in infants with blockages in the intestines.
Special Precautions & Warnings:
Pregnancy and breast-feeding: There isn't enough reliable information to know if B. breve is safe to use while pregnant or breast-feeding. But there's no reason to expect safety concerns when used appropriately under medical supervision.Children: B. breve is likely safe for most children when taken by mouth for up to one year. However, there isn't enough reliable information to know if B. breve is safe for very small premature infants. There have been cases of blood infection with B. breve in critically ill babies.
Weakened immune system: B breve has caused blood infections in a small number of people with weakened immune systems. If you have a weakened immune system, talk with your healthcare provider before taking B. breve.
Blockage in the intestines: B. breve has caused blood infections in a small number of infants who have had stomach surgery. Because the intestines became blocked, the bacteria might have crossed into the blood stream. Use cautiously or avoid in infants with blockages in the intestines.
Effectiveness
NatMed Pro rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, Ineffective, and Insufficient Evidence to Rate.
Possibly ineffective Effectiveness definitions
- Decline in memory and thinking skills that occurs normally with age. Taking B. breve by mouth doesn't seem to improve memory and thinking skills in older adults.
- Blood infection (sepsis). Adding B. breve to infant formula doesn't prevent sepsis in premature babies.
Dosing & administration
In adults, B. breve has most often been taken by mouth alone or together with other probiotics in doses of up to 20 billion colony-forming units (CFUs) daily, for up to 6 weeks. In children, B. breve has most often been taken by mouth alone or together with other probiotics in doses of 200 million-2 billion CFUs daily for up to 8 weeks. Speak with a healthcare provider to find out what dose might be best for a specific condition.
Interactions with pharmaceuticals
Antibiotic drugs
Interaction Rating=Moderate Be cautious with this combination.
B. breve is a type of friendly bacteria. Antibiotics are used to reduce harmful bacteria in the body. Taking antibiotics along with B. breve might reduce the effects of B. breve. To avoid this interaction, take B. breve products at least two hours before or after antibiotics.
Interactions with herbs & supplements
There are no known interactions with herbs and supplements.
Interactions with foods
There are no known interactions with foods.
Products
View all productsPractitioner product
Practitioner product
Practitioner product
Per capsule:
- Bifidobacterium breve (BB-18) 4 billion CFU
- Lactobacillus rhamnosus (HN001) 3 billion CFU
- Bifidobacterium animalis ssp. lactis (BS-01) 18 billion CFU
- Lactobacillus plantarum (LP-115) 7 billion CFU
- Lactobacillus acidophilus (LA-14) 6 billion CFU
- Lactobacillus salivarius (LS-33) 3 billion CFU
- Lactobacillus paracasei (LPC-37) 3 billion CFU
- Bifidobacterium bifidum (BB-06) 1 billion CFU
- Bifidobacterium longum (BL-05) 1 billion CFU
- Lactobacillus casei (LC-11) 4 billion CFU
Practitioner product
Per capsule:
Practitioner product
Practitioner product
Per capsule:
- Bifidobacterium breve (M-16V) 3 billion CFU
- Bifidobacterium longum (BB536) 5 billion CFU
- Bifidobacterium infantis (M-63) 500 million CFU
- Lactobacillus rhamnosus (HN001) 6 billion CFU
- Lactobacillus paracasei (LPC-37) 5.5 billion CFU
- Lactobacillus salivarius (LS-33) 3 billion CFU
- Lactobacillus casei (LC-11) 3 billion CFU
- Bifidobacterium animalis ssp. lactis (BI-04) 2 billion CFU
- Bifidobacterium animalis ssp. lactis (HN019) 2 billion CFU
Practitioner product
Per 1 g:
- Bifidobacterium breve (M-16V) 3 billion CFU
- Bifidobacterium longum (BB536) 5 billion CFU
- Bifidobacterium infantis (M-63) 500 million CFU
- Bifidobacterium animalis ssp. lactis (BI-04) 2 billion CFU
- Lactobacillus rhamnosus (HN001) 6 billion CFU
- Lactobacillus paracasei (LPC-37) 5.5 billion CFU
- Lactobacillus salivarius (LS-33) 3 billion CFU
- Lactobacillus casei (LC-11) 3 billion CFU
Practitioner product
Per capsule:
- Bifidobacterium breve M-16V (LMG 23729) 3 billion CFU
- Lactobacillus rhamnosus GG (ATCC 53103) 35 billion CFU
- Lactobacillus gasseri LG-36 (ATCC SD 5585) 3 billion CFU
- Bifidobacterium animalis ssp. lactis (BL-12) (ATCC 27536) 10 billion CFU
- Bifidobacterium longum BB536 (ATCC BAA-999) 1 billion CFU
- Lactobacillus paracasei LPC-37 (ATCC SD 5275) 18 billion CFU
- Lactobacillus acidophilus LA-14 (ATCC SD 5212) 10 billion CFU
- Lactobacillus plantarum LP-115 (ATCC SD 5209) 20 billion CFU
Practitioner product
Per capsule:
- Bifidobacterium breve (BR-03) 2.5 billion CFU
- Saccharomyces cerevisiae (boulardii) (SB) 10 billion CFU
- Lactobacillus plantarum (LP01) 2.5 billion CFU
- Bifidobacterium animalis ssp. lactis (BS-01) 2.5 billion CFU
- Bifidobacterium animalis ssp. lactis (BI-04) 2 billion CFU
- Bifidobacterium animalis ssp. lactis (HN019) 2 billion CFU
RRP: $49.95$37.47Save: 25%
Create account
Per capsule:
- Bifidobacterium breve (BB-18) 2 billion CFU
- Lactobacillus rhamnosus (HN001) 5 billion CFU
- Bifidobacterium animalis ssp. lactis (BI-04) 3 billion CFU
- Lactobacillus acidophilus (LA-14) 5 billion CFU
- Lactobacillus casei (LC-11) 500 million CFU
- Lactobacillus plantarum (LP-115) 5 billion CFU
- Lactobacillus gasseri (LG-36) 100 million CFU
- Streptococcus thermophilus (ST-21) 500 million CFU
- Bifidobacterium longum (BL-05) 3 billion CFU
- Lactobacillus salivarius (LS-33) 400 million CFU
- Bifidobacterium infantis (BI-26) 400 million CFU
- Lactobacillus delbrueckii ssp. bulgaricus (LB-87) lactis 100 million CFU
Practitioner product
Per capsule:
- Bifidobacterium breve (BB-23) 2 billion CFU
- Lactobacillus rhamnosus GG 20 billion CFU
- Lactobacillus casei (LC 03) 8 billion CFU
- Lactobacillus acidophilus (LA-14) 7 billion CFU
- Lactobacillus plantarum (LP01) 5 billion CFU
- Lactobacillus gasseri (LG-36) 2 billion CFU
- Bifidobacterium animalis ssp. lactis (BB-12) 5 billion CFU
- Bifidobacterium longum (BL-05) 1 million CFU
Practitioner product
Per capsule:
Practitioner product
Per 1.5 g:
- Bifidobacterium breve (M-16V) 1.5 billion CFU
- Bifidobacterium animalis ssp. lactis (CUL 34) 1 billion CFU
- Bifidobacterium bifidum (CUL 20) 50 million CFU
- Bifidobacterium infantis (M-63) 500 million CFU
- Bifidobacterium longum (BB536) 1 billion CFU
- Lactobacillus rhamnosus GG 1 billion CFU
- Bifidobacterium bifidum (CUL 73) 950 million CFU
- Lactobacillus fermentum (CUL 67) 1 billion CFU
- Cichorium intybus (root) (Chicory)
- Tapioca
- Calcium phosphate
- Zea mays (Corn starch)
- Corn maltodextrin
- Potato maltodextrin
Practitioner product
Per capsule:
- Bifidobacterium breve (BB-18) 1.4 billion CFU
- Lactobacillus acidophilus (CUL 21 + CUL 60) 7.4 billion CFU
- Bifidobacterium animalis ssp. lactis (CUL 34) 4.3 billion CFU
- Bifidobacterium bifidum (CUL 20) 225 million CFU
- Lactobacillus rhamnosus (CUL 63) 15.6 billion CFU
- Lactobacillus casei (CUL 06) 9.5 billion CFU
- Lactobacillus plantarum (CUL 66) 3.2 billion CFU
- Lactobacillus fermentum (CUL 67) 1.4 billion CFU
- Streptococcus thermophilus (CUL 68) 2.3 billion CFU
Practitioner product
Per capsule:
- Bifidobacterium breve (BB-18) 1.35 billion CFU
- Lactobacillus acidophilus (CUL 21 + CUL 60) 20 billion CFU
- Bifidobacterium animalis ssp. lactis (CUL 34) 6.55 billion CFU
- Bifidobacterium bifidum (CUL 20) 345 million CFU
- Lactobacillus rhamnosus (CUL 63) 15.55 billion CFU
- Lactobacillus casei (CUL 06) 9.45 billion CFU
- Lactobacillus plantarum (CUL 66) 3.15 billion CFU
- Lactobacillus fermentum (CUL 67) 1.35 billion CFU
- Streptococcus thermophilus (CUL 68) 2.25 billion CFU
Practitioner product
Per capsule:
- Bifidobacterium breve (CUL 69) 1.35 billion CFU
- Lactobacillus acidophilus (CUL 21 + CUL 60) 20 billion CFU
- Bifidobacterium animalis ssp. lactis (CUL 34) 6.55 billion CFU
- Bifidobacterium bifidum (CUL 20) 345 million CFU
- Lactobacillus rhamnosus (CUL 63) 15.55 billion CFU
- Lactobacillus gasseri (LG-36) 15 billion CFU
- Lactobacillus casei (CUL 06) 9.45 billion CFU
- Lactobacillus plantarum (CUL 66) 3.15 billion CFU
- Lactobacillus fermentum (CUL 67) 1.35 billion CFU
- Streptococcus thermophilus (CUL 68) 2.25 billion CFU
Practitioner product
Per capsule:
- Bifidobacterium breve (BB-18) 1 billion CFU
- Lactobacillus plantarum (LP-115) 8 billion CFU
- Lactobacillus casei (LC-11) 5 billion CFU
- Bifidobacterium animalis ssp. lactis (BI-04) 3 billion CFU
- Streptococcus thermophilus (ST-21) 1 billion CFU
- Lactobacillus paracasei (LPC-37) 6 billion CFU
- Lactobacillus acidophilus (LA-14) 3 billion CFU
- Lactobacillus gasseri (LG-36) 1.5 billion CFU
- Lactobacillus rhamnosus (LR-32) 1.5 billion CFU
- Bifidobacterium longum (BL-05) 500 million CFU
Practitioner product
Per 1 g:
- Bifidobacterium breve M-16V (LMG 23729) 1 billion CFU
- Lactobacillus rhamnosus GG (ATCC 53103) 5 billion CFU
- Bifidobacterium animalis ssp. lactis (BL-12) (ATCC 27536) 2 billion CFU
- Bifidobacterium infantis M-63 (LMG-23728) 1 billion CFU
- Bifidobacterium longum BB536 (ATCC BAA-999) 3 billion CFU
Practitioner product
Per capsule:
- Bifidobacterium breve M-16V (LMG 23729) 1 billion CFU
- Lactobacillus rhamnosus GG (ATCC 53103) 5 billion CFU
- Lactobacillus reuteri (CCFM1040) 3 billion CFU
- Lactobacillus gasseri LG-36 (ATCC SD 5585) 1 billion CFU
- Saccharomyces cerevisiae (boulardii) (CNCM I-3799) (SB) 5 billion CFU
- Bifidobacterium animalis ssp. lactis (BL-12) (ATCC 27536) 5 billion CFU
Practitioner product
vital.ly has licensed monographs from TRC Healthcare.
This monograph was last reviewed on 22/02/2023 11:00:00. Monographs are reviewed and/or updated multiple times per month and at least once per year.
Natural Medicines disclaims any responsibility related to medical consequences of using any medical product. Effort is made to ensure that the information contained in this monograph is accurate at the time it was published. Consumers and medical professionals who consult this monograph are cautioned that any medical or product related decision is the sole responsibility of the consumer and/or the health care professional. A legal License Agreement sets limitations on downloading, storing, or printing content from this Database. No reproduction of this monograph or any content from this Database is permitted without written permission from the publisher. It is unlawful to download, store, or distribute content from this site.